Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter L Jones

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
The EMBO Journal|July 4, 2003
MEKK1 regulates calpain-dependent proteolysis of focal adhesion proteins for rear-end detachment of migrating fibroblastsBruce D Cuevas, Amy N Abell, James A Witowsky, et al.
Science Advances|December 19, 2025
CRISPRa-mediated disentanglement of the Dux-MERVL axis in the 2C-like state, totipotency, and cell deathPaul Chammas, Sheila Q Xie, Lessly P Sepulveda-Rincon, et al.
Journal of Neuromuscular Diseases|August 30, 2021
Identification of Serum Interleukin 6 Levels as a Disease Severity Biomarker in Facioscapulohumeral Muscular DystrophyMarilyn Gros, Andreia M Nunes, Douglas Daoudlarian, et al.
Science Translational Medicine|March 28, 2020
Applying genome-wide CRISPR-Cas9 screens for therapeutic discovery in facioscapulohumeral muscular dystrophyAngela Lek, Yuanfan Zhang, Keryn G Woodman, et al.
The Journal of Molecular Diagnostics : JMD|March 20, 2025
4qA D4Z4 Methylation Test as a Valuable Complement for Differential Diagnosis in Patients with a Facioscapulohumeral Muscular Dystrophy-Like PhenotypeXingyu Xia, Nachuan Cheng, Yiqi Liu, et al.
Human Molecular Genetics|January 25, 2024
Regional and bilateral MRI and gene signatures in facioscapulohumeral dystrophy: implications for clinical trial design and mechanisms of disease progressionChao-Jen Wong, Seth D Friedman, Lauren Snider, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
Validation of the association between MRI and gene signatures in facioscapulohumeral dystrophy muscle: implications for clinical trial designChao-Jen Wong, Seth D Friedman, Lauren Snider, et al.
Neurology|February 5, 2022
Cross-sectional Neuromuscular Phenotyping Study of Patients With Arhinia With <i>SMCHD1</i> VariantsPayam Mohassel, Ning Chang, Kaoru Inoue, et al.
International Journal of Molecular Sciences|April 16, 2020
Interpretation of the Epigenetic Signature of Facioscapulohumeral Muscular Dystrophy in Light of Genotype-Phenotype StudiesAna Nikolic, Takako I Jones, Monica Govi, et al.
Nature Genetics|May 27, 2017
Corrigendum: SMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndromeNatalie D Shaw, Harrison Brand, Zachary A Kupchinsky, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
The EMBO Journal|July 4, 2003
MEKK1 regulates calpain-dependent proteolysis of focal adhesion proteins for rear-end detachment of migrating fibroblastsBruce D Cuevas, Amy N Abell, James A Witowsky, et al.
Science Advances|December 19, 2025
CRISPRa-mediated disentanglement of the Dux-MERVL axis in the 2C-like state, totipotency, and cell deathPaul Chammas, Sheila Q Xie, Lessly P Sepulveda-Rincon, et al.
Journal of Neuromuscular Diseases|August 30, 2021
Identification of Serum Interleukin 6 Levels as a Disease Severity Biomarker in Facioscapulohumeral Muscular DystrophyMarilyn Gros, Andreia M Nunes, Douglas Daoudlarian, et al.
Science Translational Medicine|March 28, 2020
Applying genome-wide CRISPR-Cas9 screens for therapeutic discovery in facioscapulohumeral muscular dystrophyAngela Lek, Yuanfan Zhang, Keryn G Woodman, et al.
The Journal of Molecular Diagnostics : JMD|March 20, 2025
4qA D4Z4 Methylation Test as a Valuable Complement for Differential Diagnosis in Patients with a Facioscapulohumeral Muscular Dystrophy-Like PhenotypeXingyu Xia, Nachuan Cheng, Yiqi Liu, et al.
Human Molecular Genetics|January 25, 2024
Regional and bilateral MRI and gene signatures in facioscapulohumeral dystrophy: implications for clinical trial design and mechanisms of disease progressionChao-Jen Wong, Seth D Friedman, Lauren Snider, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
Validation of the association between MRI and gene signatures in facioscapulohumeral dystrophy muscle: implications for clinical trial designChao-Jen Wong, Seth D Friedman, Lauren Snider, et al.
Neurology|February 5, 2022
Cross-sectional Neuromuscular Phenotyping Study of Patients With Arhinia With <i>SMCHD1</i> VariantsPayam Mohassel, Ning Chang, Kaoru Inoue, et al.
International Journal of Molecular Sciences|April 16, 2020
Interpretation of the Epigenetic Signature of Facioscapulohumeral Muscular Dystrophy in Light of Genotype-Phenotype StudiesAna Nikolic, Takako I Jones, Monica Govi, et al.
Nature Genetics|May 27, 2017
Corrigendum: SMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndromeNatalie D Shaw, Harrison Brand, Zachary A Kupchinsky, et al.
Pageof 8